Skip to main content

Incyte to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026 at 8:40 a.m. EDT.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation and Autoimmunity.

To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X, and Instagram

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.03
-7.76 (-3.06%)
AAPL  307.34
-3.89 (-1.25%)
AMD  466.38
-56.82 (-10.86%)
BAC  53.83
-0.06 (-0.11%)
GOOG  365.76
-3.51 (-0.95%)
META  593.00
-34.57 (-5.51%)
MSFT  416.67
-11.38 (-2.66%)
NVDA  205.10
-13.56 (-6.20%)
ORCL  213.68
-22.66 (-9.59%)
TSLA  391.00
-27.45 (-6.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.